Amy Loriaux, PhD

Health Industry and Standards Writer

Amy Loriaux is the Health Industry and Standards Writer for IMO. She joined in 2020 to create content that informs product strategy, educates customers, and facilitates internal and external communication. She works closely with the Strategy, Product, and Marketing teams, as well as IMO’s development partners. She received her PhD in Psychology from the University of Illinois at Chicago in 2013 and has extensive research experience in the biological sciences. Amy belongs to an amateur, all women’s barbershop-style chorus and is an avid CrossFitter.

More from Amy Loriaux, PhD

In search of a faster, more accurate way to identify patient cohorts, Duke Health turned to IMO’s extensive code maps to help build a solution.
Duke Health’s IMO-enabled computational phenotype has dramatically improved their ability to quickly and accurately identify specific patient cohorts.
Standardizing meds and labs data can benefit both your organization and healthcare as a whole – but the task can be challenging.
Clinical terminology plays an important role in EHRs and provider workflows. But what about when it comes to cohorting patients?
Learn how the University of Manchester leveraged IMO’s robust clinical interface terminology to help drive their COVID-19 shielding algorithm.
Large-scale clinical research endeavors are a challenge – but are necessary to produce actionable clinical data. Learn how OMOP can help.
IMO’s CMO, Andrew S. Kanter, MD, answers questions on monkeypox and what the health IT industry can do to help clinicians stay on top of the outbreak.
Measuring the results of value-based care can be a challenge. This white paper discusses PROMs, or patient-reported outcome measures, and how to integrate them into the EHR for maximum utility.
In this insight brief, we explore the tools needed to ensure accuracy when collecting data about the pandemic; the challenges of dealing with multiple variant terminologies; and the struggle to connect variant information with individual patient records.
As the pandemic continues, the populations deemed “high risk” are increasingly fluid. From the elderly, to those with certain comorbidities, to people of color, the sands are shifting and physicians must stay focused on identifying the most at-risk patients at any given time.
The rapid development of a safe and effective COVID-19 vaccine has brought a number of challenges into sharp focus in recent months. From testing and approvals, to patient prioritization and distribution, the process is multi-faceted and highly complex. Inoculating hundreds of millions of Americans is a monumental task, but health IT is uniquely positioned to help.
As those administering the vaccines grapple with multiple moving parts, competing priorities, and the race against emerging virus variants; the need to capture, manage, and optimize inoculation data has come into sharp focus.